首页> 外国专利> Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)

Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)

机译:通过过度表达或刺激内皮蛋白C受体(EPCR)抑制恶性间皮瘤

摘要

The influence of TF, endothelial cell protein C receptor (EPCR) and protease activated receptor-1 (PAR1) on tumor growth of malignant pleural mesothelioma (MPM) is disclosed. MPM cells that lack or express TF, EPCR or PAR1 and a murine orthotopic model of MPM led to the discovery that intrapleural administration into nude mice of REN MPM cells expressing TF and PAR1 but lacking EPCR and PAR2 generated large pleural cavity tumors. Suppression of TF or PAR1 expression markedly reduced tumor growth. Overexpression of TF in non-aggressive MPM cells expressing EPCR and PAR1 but exhibiting minimal levels of TF failed to alter their tumorigenicity. Introduction of EPCR expression in aggressive MPM cells attenuated tumor growth whereas EPCR silencing in non-aggressive MPM cells overexpressing TF increased tumorigenicity of non-aggressive cells. Expression of EPCR by MPM cells suppresses tumor growth and treats MPM.
机译:公开了TF,内皮细胞蛋白C受体(EPCR)和蛋白酶激活受体-1(PAR1)对恶性胸膜间皮瘤(MPM)肿瘤生长的影响。缺少或表达TF,EPCR或PAR1的MPM细胞以及MPM的小鼠原位模型导致发现,对裸鼠施予REN的MPM细胞裸鼠表达TF和PAR1,但缺少EPCR和PAR2会产生大的胸膜腔肿瘤。 TF或PAR1表达的抑制显着降低了肿瘤的生长。在表达EPCR和PAR1但表现出最低水平的TF的非侵害性MPM细胞中TF的过表达未能改变其致瘤性。在侵略性MPM细胞中引入EPCR表达可减弱肿瘤的生长,而在过度表达TF的非侵害性MPM细胞中使EPCR沉默可增加非侵害性细胞的致瘤性。 MPM细胞表达EPCR可抑制肿瘤生长并治疗MPM。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号